FBIO
FBIO
NASDAQ · Biotechnology

Fortress Biotech Inc

$2.41
+0.11 (+4.78%)
As of May 16, 9:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
73.32M
Net Income
7.90M
Gross Margin
66.9%
Profit Margin
10.8%
Rev Growth
-5.8%
D/E Ratio
1.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 66.9% 66.9% 45.7% 45.7%
Operating Margin -68.1% -61.3% -4.5% -4.2%
Profit Margin 10.8% 10.2% -3.3% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 73.32M 77.85M 15.02M 12.01M
Gross Profit 49.06M 52.10M 6.86M 5.49M
Operating Income -49,944,472 -47,727,781 -676,721 -503,400
Net Income 7.90M 7.55M -500,427 -503,355
Gross Margin 66.9% 66.9% 45.7% 45.7%
Operating Margin -68.1% -61.3% -4.5% -4.2%
Profit Margin 10.8% 10.2% -3.3% -4.2%
Rev Growth -5.8% -5.8% +23.3% -6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 21.02M 21.02M 48.01M 47.34M
Total Equity 17.62M 17.62M 62.00M 58.63M
D/E Ratio 1.19 1.19 0.77 0.81
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,637,791 -24,852,305 -867,054 -674,727
Free Cash Flow -309,659 -330,972